Intra-Cellular Therapies, Inc. (ITCI)
After hours:
| Previous Close | 65.56 |
| Open | 65.75 |
| Bid | 64.94 x 100 |
| Ask | 65.04 x 100 |
| Day's Range | 64.93 - 66.71 |
| 52 Week Range | 45.50 - 84.89 |
| Volume | |
| Avg. Volume | 977,998 |
| Market Cap | 6.858B |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.16 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 91.64 |
Simply Wall St.Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
Insider MonkeyIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
GlobeNewswireIntra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences: 2024 RBC Capital Markets Global Healthcare ConferenceTuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY Bank of America Healthcare Conference 2024Thursday, May 16, 2024 at 9:20 a.m. PT (12:2
